Cell cycle parameters and DNA ploidy in colorectal carcinomas

Area of Science:

• Oncology
• Cell Biology
• Gastrointestinal Cancer Research

Background:

• Accurate assessment of tumor cell proliferation is crucial for understanding cancer progression and treatment response.
• Traditional methods for cell cycle analysis often involve in vitro disaggregation of tumor tissues, which can introduce artifacts and alter cellular behavior.

Purpose of the Study:

• To establish and validate a novel in vivo method for quantifying cell cycle kinetics in gastrointestinal tumors.
• To assess the feasibility of using sequential iododeoxyuridine (IUdR) and bromodeoxyuridine (BrdU) labeling for in vivo cell proliferation studies.

Main Methods:

• Seven patients with colorectal adenocarcinoma and one with anorectal squamous cell carcinoma received sequential intravenous infusions of IUdR and BrdU.
• Tumor biopsy specimens were analyzed using monoclonal antibodies to identify and quantify labeled cells, determining the labeling index and S-phase duration.
• Feulgen-stained smears underwent image analysis to measure DNA content and assess ploidy.

Main Results:

• The labeling index in tumors ranged from 17.3% to 35.6%, with a mean S-phase duration of 18.73 hours.
• Total cell cycle time varied from 39.4 to 123.4 hours, with a mean of 76.78 hours.
• Image analysis revealed that all tumors were hyperdiploid with multiple modal values.

Conclusions:

• In vivo labeling with IUdR and BrdU is a feasible and effective method for measuring cell cycle kinetics in gastrointestinal tumors.
• This approach preserves tumor architecture and avoids artifacts associated with in vitro sample processing.
• The study provides valuable insights into the proliferative characteristics of these specific gastrointestinal cancers.